Your browser doesn't support javascript.
loading
Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK.
Zhang, Qian; Wang, Hong Y; Nayak, Anindita; Nunez-Cruz, Selene; Slupianek, Artur; Liu, Xiaobin; Basappa, Johnvesly; Fan, Jing-Song; Chekol, Seble; Nejati, Reza; Bogusz, Agata M; Turner, Suzanne D; Swaminathan, Kunchithapadam; Wasik, Mariusz A.
Afiliação
  • Zhang Q; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wang HY; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nayak A; Department of Biological Sciences, National University of Singapore, Singapore.
  • Nunez-Cruz S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Slupianek A; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Liu X; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Basappa J; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Fan JS; Department of Biological Sciences, National University of Singapore, Singapore.
  • Chekol S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nejati R; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Bogusz AM; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Turner SD; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Swaminathan K; Department of Biological Sciences, National University of Singapore, Singapore.
  • Wasik MA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: mariusz.wasik@fcc
Am J Pathol ; 192(8): 1186-1198, 2022 08.
Article em En | MEDLINE | ID: mdl-35640677
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_lymphomas_multiple_myeloma Assunto principal: Proteínas de Transporte / Linfoma de Células T / Fatores de Transcrição HES-1 / Quinase do Linfoma Anaplásico Limite: Humans Idioma: En Revista: Am J Pathol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_lymphomas_multiple_myeloma Assunto principal: Proteínas de Transporte / Linfoma de Células T / Fatores de Transcrição HES-1 / Quinase do Linfoma Anaplásico Limite: Humans Idioma: En Revista: Am J Pathol Ano de publicação: 2022 Tipo de documento: Article